Episode 8 of the 'Better Testing, Better Treatment' podcast welcomes our special guests, Dr. Chandler Park, co-director of GU cancer clinical trials at Norton Cancer Institute, and Dr. Sameer Talwalkar, board-certified Hematopathologist and Molecular Pathologist at CPA Lab, Norton Healthcare.

In episode 7, our guests Anna Considine, Consultant Cancer Genetic Counsellor and Samantha Butler, Principal Clinical Scientist explore how genetic testing for inherited cancer has evolved over the last 20 years, transforming both clinical practice and patient care.

In this podcast, Professor Ferlicot, an anatomopathologist, and Dr. Mario Terlizzi, a radiation oncologist, will explore AI's applications in prostate cancer care, including diagnostics (imaging and histological assessment), and therapeutics.

Dr. James Solomon, Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine and Assistant Attending Physician at the New York Presbyterian Hospital and Dr. Ashish Saxena, Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital discuss the diverse and rapidly evolving but highly important topic of practical considerations for oncogenic fusion detection and reporting.  

Professor. Frederique Penault-Llorca, CEO of the Comprehensive Regional Cancer Institute Centre Jean PERRIN, Clermont-Ferrand, France and Deputy President, UNICANCER, and Professor Pascal Pujol, Head of Cancer Genetics department at the University Hospital of Montpellier, France and President of the French Society of Predictive and Personalized Medicine (SFMPP) will discuss the topic of implementing targeted therapies in cancer from a European perspective. 

Pathologist, Dr. Dhanpat Jain is a Professor of Pathology and Internal Medicine (section of Digestive Diseases) at Yale School of Medicine, and oncologist, Dr. Stacey Stein, is an Associate Professor of Medicine, also at the Yale School of Medicine. During this podcast, they will discuss the topic of implementing targeted therapies in gastric cancer.  

Oncologist, Dr. Elie Rassy, and pathologist, Dr. Magali Lacroix-Triki, from the Gustave Roussy Cancer Campus, dive into discussions about the profound impact that AI has brought to breast cancer diagnosis. By listening to this podcast, you will learn about current projects utilizing artificial intelligence, the challenges that AI brings to pathology labs and the future potential of this innovative technology.

This podcast focuses on the topic of HRD testing from both a clinician and pathologist point of view and is now available to listen in full